300439.SZ SHZ
Medicalsystem Biotechnology Co., Ltd.
1W: +1.7%
1M: +7.7%
3M: +22.8%
YTD: -1.0%
1Y: -13.0%
3Y: -5.9%
5Y: -45.6%
¥10.25 ($1.53)
+0.11 (+1.08%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$1.7B
-7.6% ▼
5Y CAGR: -11.1%
Gross Profit
$776M
-1.2% ▼
5Y CAGR: -6.3%
Operating Income
$268M
-4.2% ▼
5Y CAGR: -8.2%
Net Income
$258M
+0.6% ▲
EPS (Diluted)
$0.67
+0.0% ▲
EBITDA
$495M
+4.2% ▲
5Y CAGR: -2.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $2.3B | $2.3B | $2.5B | $1.9B | $1.7B |
| YoY Growth | -26.5% | -2.2% | +10.6% | -24.2% | -7.6% |
| Cost of Revenue | $1.5B | $1.3B | $1.5B | $1.1B | $966M |
| Gross Profit | $848M | $911M | $950M | $786M | $776M |
| Gross Margin | 36.8% | 40.5% | 38.2% | 41.7% | 44.6% |
| R&D Expenses | $135M | $151M | $172M | $138M | $146M |
| SG&A Expenses | $336M | $352M | $365M | $192M | $153M |
| Operating Expenses | $580M | $615M | $637M | $553M | $509M |
| Operating Income | $461M | $294M | $322M | $279M | $268M |
| Operating Margin | 20.0% | 13.1% | 12.9% | 14.8% | 15.4% |
| Interest Expense | $55M | $30M | $16M | $11M | $3M |
| Income Before Tax | $347M | $218M | $223M | $296M | $282M |
| Tax Expense | $53M | $28M | $18M | $36M | $20M |
| Net Income | $299M | $179M | $199M | $257M | $258M |
| Net Margin | 13.0% | 8.0% | 8.0% | 13.6% | 14.8% |
| EPS (Diluted) | $0.87 | $0.48 | $0.52 | $0.67 | $0.67 |
| EBITDA | $590M | $442M | $431M | $475M | $495M |
| Shares Outstanding | 344M | 374M | 383M | 383M | 385M |